Last updated: August 19, 2024
Sponsor: Hong Kong Baptist University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Constipation
Treatment
SCD-2101
Clinical Study ID
NCT06534996
REC/23-24/0482
Ages > 60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- (1) Age ≥ 60 years old (2) Meet the Rome IV diagnostic criteria for functionalconstipation (3) Complete spontaneous bowel movements ≤ 2 times per week, to beassessed based on a 2-week electronic diary record (CSBMs are defined as the numberof times within a 24-hour period that the patient can defecate spontaneously withoutthe use of laxatives or enemas and feels that the stool is completely evacuated) (4)Have colonoscopy results with a diagnosis of no significant abnormalities seen or nomore than 3 colorectal polyps, each less than 0.5 cm in size (based on resultswithin the last 5 years before screening) (5) Understand and be able to followwritten and oral instructions in Chinese (6) Capable of independently using WhatsAppand an electronic diary, and completing a 2-week electronic diary record during thescreening period (7) The subject is informed and voluntarily signs the informedconsent form.
Exclusion
Exclusion Criteria:
- (1) Secondary constipation (constipation caused by drugs or other diseases); (2)Currently using or requiring continued use of medications that may affect theoutcomes of the trial (including but not limited to: antibiotics, hormonal drugs,analgesics, neurotransmitter drugs, gut flora-regulating medications, etc.); (3)Colonoscopy or sigmoidoscopy reveals clinically significant abnormalities; (4)Clinically significant abnormalities in laboratory tests or imaging examinationswithin the last 6 months; (5) History of allergy to traditional Chinese medicine; (6) History of abdominal surgery within the past year (except for laparoscopicappendectomy); (7) Patients with psychiatric diseases or those requiring the use ofpsychotropic drugs; (8) Deemed by the researchers as unsuitable to participate inthis study for psychological or physical reasons.
Study Design
Total Participants: 14
Treatment Group(s): 1
Primary Treatment: SCD-2101
Phase:
Study Start date:
August 01, 2024
Estimated Completion Date:
November 30, 2024
Study Description
Connect with a study center
Hong Kong Baptist University
Kowloon Tong,
Hong KongActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.